SIGA Technologies Inc. (SIGA)
NASDAQ: SIGAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SIGA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $172.45M
- P/E (TTM)
- 240.00
- Forward P/E
- 5.45
- EPS (TTM)
- $0.01
- Dividend yield
- None
- Ex-dividend date
- Apr 7, 2026
- 52-week range
- 2.30 – 7.11
- Day range
- 2.30 – 2.65
- Volume / Avg
- 788.24K / 617.60K
- Beta
- —
- Shares outstanding
- 71.86M
52-week range
SIGA stock today
Shares of SIGA Technologies (SIGA) finished lower on Nov 20 at $2.40, a drop of 9.43% or $0.25 per share, versus the S&P 500's 3.70% decline. At this level, SIGA sits near the bottom of its 52-week range of $2.30 to $7.11: 66.2% below the high, set on Feb 3, 2026 and 4.3% above the low. SIGA is down 60.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 58.9%.
SIGA Technologies trades at 240.0x its trailing twelve-month earnings per share of $0.01. Its forward P/E of 5.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About SIGA Technologies
Company profileSIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Diem Nguyen M.B.A., Ph.D.
- Headquarters
- New York, NY
- Employees
- 49
- Website
- siga.com
Financial highlights
Full financialsIn fiscal 2025, SIGA Technologies generated $94.6 million in revenue, down 31.8% from fiscal 2024, its first annual decline since 2024. Net income was $23.3 million (-60.7% year over year), for a net margin of 24.6% versus a median of 45.1% in the prior 5 years. Gross margin was 68.6% (down from 77.4%) and operating margin 25.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $94.57M | $138.72M | $139.92M | $110.78M | $133.67M |
| Growth | -31.82% | -0.86% | +26.31% | -17.13% | +6.97% |
| Net income | $23.28M | $59.21M | $68.07M | $33.90M | $69.45M |
| EPS (diluted) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 |
Analyst forecast
ForecastConsensus (1 analysts)
strong_buy
Avg. price target
$3.25+35.42%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $-0.09 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.60
- Ex-dividend date
- Apr 7, 2026
SIGA news
All SIGA news- SIGA (SIGA) Q3 2026 Earnings Call TranscriptNasdaq
- SIGA Technologies, Inc. Reports $15 Million Procurement Contract and Financial Results for Three and Nine Months Ended September 30, 2026Nasdaq
- SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026GlobeNewswire
- SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.GlobeNewswire
- SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial ResultsGlobeNewswire
- SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®GlobeNewswire
SIGA Technologies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs SIGA |
| VOGXVogenx Inc | 11.87 | -7.30% | $176.33M | vs SIGA |
| NATRNature's Sunshine Products Inc. | 10.18 | +0.10% | $176.41M | vs SIGA |
| KRROKorro Bio Inc. | 12.18 | -0.08% | $167.18M | vs SIGA |
| ABEOAbeona Therapeutics Inc. | 2.42 | -1.22% | $165.31M | vs SIGA |
| ADCTADC Therapeutics SA | 1.28 | -1.54% | $180.05M | vs SIGA |
| SLGLSol-Gel Technologies Ltd. | 55.17 | +2.02% | $180.63M | vs SIGA |
| WHWKWhitehawk Therapeutics Inc. | 3.07 | -1.60% | $181.16M | vs SIGA |
Indexes, lists and sector
SIGA Technologies stock FAQ
What is SIGA Technologies's stock price today?
SIGA last traded at $2.40 as of Nov 20, 4:00 PM EST, down 9.43% on the day. Prices are delayed at least 15 minutes.
Does SIGA Technologies pay a dividend?
Yes. SIGA Technologies pays $0.00 per share annually. The most recent dividend of $0.60 had an ex-dividend date of Apr 7, 2026.
What is SIGA's P/E ratio?
SIGA trades at a trailing P/E ratio of 240.00 and a forward P/E of 5.45.
Who is SIGA Technologies's CEO?
Dr. Diem Nguyen M.B.A., Ph.D. is the chief executive officer of SIGA Technologies Inc., which has about 49 employees.
What is the SIGA 52-week high?
The 52-week high for SIGA is $7.11 and the 52-week low is $2.30. The stock is currently 66.2% below its high.